Mrinal M Gounder (Mrinal Gounder)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Combination Therapy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer discovery

Clinical cancer research : an official journal of the American Association for Cancer Research

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

This page only lists publications with an associated author ORCID identifier.

Publications

Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Evan Rosenbaum, Kenneth P Seier, Martina Bradic, Ciara M Kelly, Sujana Movva, Benjamin A Nacev, Mrinal M Gounder, Mary Louise Keohan, Viswatej Avutu, Ping Chi, Katherine A Thornton, Jason E Chan, Mark A Dickson, Mark T A Donoghue, William D Tap, Li-Xuan Qin, Sandra P D' Angelo
Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas. Cancer research communications (2023)
Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley, Cristina R Antonescu, Rodrigo Gularte-Mérida, Marimar Benitez, Juliana I Delgado, Raghu P Kataru, Mark Wei Yi Tan, Martina Bradic, Travis E Adamson, Kenneth P Seier, Allison L Richards, Marta Palafox, Eric Chan, Sandra P D' Angelo, Mrinal M Gounder, Mary Louise Keohan, Ciara M Kelly, Ping Chi, Sujana Movva, Jonathan Landa, Aimee M Crago, Mark T A Donoghue, Li-Xuan Qin, Violeta Serra, Mesruh Turkekul, Afsar Barlas, Daniel M Firester, Katia Manova, Babak J Mehrara, Marta Kovatcheva, Nguan Soon Tan, Samuel Singer, William D Tap, Andrew Koff
Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Amy M Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru, Feng Xu, Robert C Doebele, David S Hong
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Patricia M LoRusso, Noboru Yamamoto, Manish R Patel, Scott A Laurie, Todd M Bauer, Junxian Geng, Teffany Davenport, Michael Teufel, Jian Li, Mehdi Lahmar, Mrinal M Gounder
The MDM2-p53 antagonist BI 907828 in patients with advanced or metastatic solid tumors: results of a phase Ia, first-in-human, dose-escalation study. Cancer discovery (2023)
Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Amy M Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru, Feng Xu, Robert C Doebele, David S Hong
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Amy M Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru, Feng Xu, Robert C Doebele, David S Hong
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Amy M Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru, Feng Xu, Robert C Doebele, David S Hong
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mrinal M Gounder, Thomas M Atkinson, Timothy Bell, Christina Daskalopoulou, Pip Griffiths, Moriah Martindale, L Mary Smith, Allison Lim
GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS © ): psychometric properties and clinically meaningful thresholds as assessed in the Phase 3 DeFi randomized controlled clinical trial. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2023)
Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Amy M Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru, Feng Xu, Robert C Doebele, David S Hong
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Amy M Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru, Feng Xu, Robert C Doebele, David S Hong
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Amy M Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru, Feng Xu, Robert C Doebele, David S Hong
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, Allison L Richards, Viswatej Avutu, Jason E Chan, Ping Chi, Mark A Dickson, Mrinal M Gounder, Mary Louise Keohan, Sujana Movva, Benjamin A Nacev, Evan Rosenbaum, Travis E Adamson, Samuel Singer, Madalyn G Neuwirth, Aimee M Crago, Sam S Yoon, Sinchun Hwang, Joseph Patrick Erinjeri, Cristina R Antonescu, William D Tap, Sandra P D' Angelo
A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jia Hu, Meera R Hameed, Narasimhan P Agaram, Karissa A Whiting, Li-Xuan Qin, Anthony M Villano, Rachael B O'Connor, Julian M Rozenberg, Sonia Cohen, Katherine Prendergast, Sara Kryeziu, Richard L White, Mitchell C Posner, Nicholas D Socci, Mrinal M Gounder, Samuel Singer, Aimee M Crago
PDGFRβ signaling cooperates with β-catenin to modulate c-Abl and biologic behavior of desmoid-type fibromatosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ping Chi, Li-Xuan Qin, Bastien Nguyen, Ciara M Kelly, Sandra P D' Angelo, Mark A Dickson, Mrinal M Gounder, Mary L Keohan, Sujana Movva, Benjamin A Nacev, Evan Rosenbaum, Katherine A Thornton, Aimee M Crago, Sam Yoon, Gary A Ulaner, Randy Yeh, Moriah Martindale, Haley T Phelan, Matthew D Biniakewitz, Sarah Warda, Cindy J Lee, Michael F Berger, Samuel Singer, Sinchun Hwang, Yu Chen, Cristina R Antonescu, William D Tap
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (9) (2022)
Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martín-Broto, Giovanni Grignani, Scott M Schuetze, Bruno Vincenzi, Andrew J Wagner, Bartosz Chmielowski, Robin L Jones, Richard F Riedel, Silvia Stacchiotti, Elizabeth Trice Loggers, Kristen N Ganjoo, Axel Le Cesne, Antoine Italiano, Xavier García Del Muro Solans, Melissa Burgess, Sophie Piperno-Neumann, Christopher Ryan, Mary F Mulcahy, Charles Forscher, Nicolas Penel, Scott H Okuno, Anthony D Elias, Lee Hartner, Tony Philip, Thierry Alcindor, Bernd Kasper, Peter Reichardt, Lore D F Lapeire, Jean Yves Blay, Christine Chevreau, Claudia Maria Valverde Morales, Gary K Schwartz, James L Chen, Hari Deshpande, Elizabeth J Davis, Garth Nicholas, Stefan Gröschel, Helen Hatcher, Florence Duffaud, Antonio Casado Herráez, Roberto Diaz Beveridge, Giuseppe Badalamenti, Mikael Eriksson, Christian F Meyer, Margaret von Mehren, Brian Andrew Van Tine, Katharina S Götze, Filomena Mazzeo, Alexander Yakobson, Aviad Zick, Alexander T J Lee, Anna Estival Gonzalez, Andrea Napolitano, Mark A Dickson, Dayana Michel, Chang-Ting Meng, Lingling Li, Jianjun Liu, Osnat Ben-Shahar, Dane R Van Domelen, Christopher J Walker, Hua Chang, Yosef Landesman, Jatin J Shah, Sharon Shacham, Michael G Kauffman, Steven Attia
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Aditya Bardia, Mrinal M Gounder, Jordi Rodon, Filip Janku, Martijn P Lolkema, Joe J Stephenson, Philippe L Bedard, Martin Schuler, Cristiana Sessa, Patricia LoRusso, Michael Thomas, Heiko Maacke, Helen Evans, Yongjian Sun, Daniel S W Tan
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations. The oncologist 25 (1) (2019)